Copyright
©The Author(s) 2023.
World J Gastrointest Surg. Aug 27, 2023; 15(8): 1673-1683
Published online Aug 27, 2023. doi: 10.4240/wjgs.v15.i8.1673
Published online Aug 27, 2023. doi: 10.4240/wjgs.v15.i8.1673
Table 1 Baseline data and pathological features of the study participants
Characteristics | n (%) |
Gender | |
Male | 117 (55.19) |
Female | 95 (44.81) |
Tumor site | |
Upper third | 5 (2.36) |
Middle third | 58 (27.36) |
Lower third | 149 (70.28) |
pT | |
pT1-2 | 79 (37.26) |
pT3-4 | 133 (62.74) |
pN | |
pN0 | 94 (44.34) |
pN1-3 | 118 (55.66) |
pTNM stage | |
Ⅰ/Ⅱ | 117 (55.19) |
Ⅲ | 95 (44.81) |
Resection scope | |
Distal stomach | 167 (78.78) |
Total stomach | 45 (21.23) |
Survival status | |
Survival | 125 (58.96) |
Dead | 87 (41.04) |
Table 2 Receiver operating characteristic curve analysis results of predictors
Variables | AUC (95%CI) | P value | Cut-off value | Sensitivity | Specificity |
Age | 0.589 (0.509-0.669) | 0.028 | 55.5 | 0.494 | 0.728 |
PLR | 0.589 (0.511-0.666) | 0.028 | 124.63 | 0.586 | 0.608 |
LMR | 0.590 (0.512-0.669) | 0.025 | 3.83 | 0.54 | 0.632 |
ALB | 0.618 (0.540-0.696) | 0.004 | 38.95 | 0.414 | 0.792 |
PNI | 0.644 (0.567-0.721) | < 0.001 | 49.85 | 0.632 | 0.608 |
FIB | 0.624 (0.547-0.701) | 0.002 | 3.115 | 0.655 | 0.648 |
CEA | 0.632 (0.556-0.708) | 0.001 | 1.455 | 0.471 | 0.744 |
Table 3 Relationship between baseline data, pathological features and 5-year survival rate
Group | Survival status | 5-OS (%) | χ2 | P value | |
Survival (n) | Dead (n) | ||||
Gender | 1.27 | 0.26 | |||
Male | 73 | 44 | 62.39 | ||
Female | 52 | 43 | 54.74 | ||
Tumor site | 3.556 | 0.169 | |||
Upper third | 1 | 4 | 20 | ||
Middle third | 33 | 25 | 56.9 | ||
Lower third | 91 | 58 | 61.07 | ||
pT | 49.726 | < 0.001 | |||
pT1-2 | 71 | 8 | 89.87 | ||
pT3-4 | 54 | 79 | 40.6 | ||
pN | 30.269 | < 0.001 | |||
pN0 | 75 | 19 | 79.79 | ||
pN1-3 | 50 | 68 | 42.37 | ||
pTNM stage | 49.322 | < 0.001 | |||
Ⅰ/Ⅱ | 94 | 23 | 80.34 | ||
Ⅲ | 31 | 64 | 32.63 | ||
Resection scope | 8.489 | 0.004 | |||
Distal stomach | 107 | 60 | 64.07 | ||
Total stomach | 18 | 27 | 40 |
Table 4 Relationship between indicators and survival status
Variables | Survival | Dead | t/Z value | P value |
Age | 50 ± 10.82 | 53 ± 11.65 | -2.213 | 0.028 |
CEA | 0.90 (0.58, 1.48) | 1.21 (0.75, 2.35) | -3.265 | 0.001 |
NLR | 1.82 (1.30, 2.43) | 2.05 (1.45, 2.71) | -1.668 | 0.095 |
PLR | 118.33 (99.41, 150.18) | 130.59 (108.10, 162.00) | -2.196 | 0.028 |
LMR | 4.20 (3.40, 5.67) | 3.80 (2.80, 5.00) | -2.226 | 0.026 |
SII | 392.36 (275.38, 565.21) | 448.00 (311.67, 600.71) | -1.391 | 0.164 |
PT | 12.40 (11.96, 12.90) | 12.30 (12.00, 12.70) | -1.114 | 0.265 |
INR | 0.97 (0.93, 1.02) | 0.95 (0.93, 0.99) | -1.728 | 0.084 |
APTT | 32.71 ± 4.16 | 31.90 ± 3.98 | 1.425 | 0.156 |
TT | 17.55 ± 1.73 | 17.66 ± 1.85 | -0.424 | 0.672 |
FIB | 2.93 (2.56, 3.42) | 3.29 (2.81, 3.80) | -3.065 | 0.002 |
ALB (g/L) | 41.79 ± 3.83 | 40.09 ± 4.72 | 2.854 | 0.005 |
GLB (g/L) | 26.00 (23.80, 29.40) | 25.20 (22.80, 28.50) | -1.356 | 0.175 |
AGR | 1.58 (1.41, 1.80) | 1.56 (1.40, 1.75) | -0.716 | 0.474 |
PNI | 51.11 ± 4.95 | 48.21 ± 6.15 | 3.789 | < 0.001 |
Table 5 Grouping of predictors
Survival (n) | Dead (n) | 5-OS (%) | Total | ||
Age | < 56 | 91 | 44 | 67.41 | 135 |
≥ 56 | 34 | 43 | 44.16 | 77 | |
CEA (ng/mL) | < 1.455 | 93 | 46 | 66.91 | 139 |
≥ 1.455 | 32 | 41 | 43.84 | 73 | |
PLR | < 124.63 | 76 | 36 | 67.86 | 112 |
≥ 124.63 | 49 | 51 | 49 | 100 | |
LMR | < 3.83 | 81 | 30 | 72.97 | 111 |
≥ 3.83 | 44 | 57 | 43.56 | 101 | |
ALB (g/L) | < 38.95 | 26 | 36 | 41.94 | 62 |
≥ 38.95 | 99 | 51 | 66 | 150 | |
PNI | < 49.85 | 49 | 55 | 47.12 | 104 |
≥ 49.85 | 76 | 32 | 70.37 | 108 | |
FIB (g/L) | < 3.115 | 46 | 47 | 49.46 | 93 |
≥ 3.115 | 79 | 40 | 66.39 | 119 |
- Citation: Liu HL, Feng X, Tang MM, Zhou HY, Peng H, Ge J, Liu T. Prognostic significance of preoperative lymphocyte to monocyte ratio in patients with signet ring gastric cancer. World J Gastrointest Surg 2023; 15(8): 1673-1683
- URL: https://www.wjgnet.com/1948-9366/full/v15/i8/1673.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v15.i8.1673